121 related articles for article (PubMed ID: 20646738)
1. Oligoarray comparative genomic hybridization of renal cell tumors that developed in patients with acquired cystic renal disease.
Kuntz E; Yusenko MV; Nagy A; Kovacs G
Hum Pathol; 2010 Sep; 41(9):1345-9. PubMed ID: 20646738
[TBL] [Abstract][Full Text] [Related]
2. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis.
Inoue H; Nonomura N; Kojima Y; Shiba M; Oka D; Arai Y; Nakayama M; Takayama H; Nishimura K; Mori H; Okuyama A
Nephrol Dial Transplant; 2007 Jul; 22(7):2052-5. PubMed ID: 17438007
[TBL] [Abstract][Full Text] [Related]
4. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study.
Kuroda N; Shiotsu T; Kawada C; Shuin T; Hes O; Michal M; Ohe C; Mikami S; Pan CC
Ann Diagn Pathol; 2011 Aug; 15(4):282-5. PubMed ID: 20952286
[TBL] [Abstract][Full Text] [Related]
5. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies.
Vieira J; Henrique R; Ribeiro FR; Barros-Silva JD; Peixoto A; Santos C; Pinheiro M; Costa VL; Soares MJ; Oliveira J; Jerónimo C; Teixeira MR
Genes Chromosomes Cancer; 2010 Oct; 49(10):935-47. PubMed ID: 20629095
[TBL] [Abstract][Full Text] [Related]
7. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
[TBL] [Abstract][Full Text] [Related]
10. Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.
Dagher J; Kammerer-Jacquet SF; Dugay F; Beaumont M; Lespagnol A; Cornevin L; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA
Virchows Arch; 2017 Jul; 471(1):107-115. PubMed ID: 28488172
[TBL] [Abstract][Full Text] [Related]
11. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.
Rao P; Monzon F; Jonasch E; Matin SF; Tamboli P
Hum Pathol; 2014 Sep; 45(9):1966-72. PubMed ID: 25081542
[TBL] [Abstract][Full Text] [Related]
12. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
[TBL] [Abstract][Full Text] [Related]
13. Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Ohe C; Mikami S; Inoue K; Nagashima Y; Cohen RJ; Pan CC; Michal M; Hes O
Histol Histopathol; 2012 Aug; 27(8):969-74. PubMed ID: 22763870
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
[TBL] [Abstract][Full Text] [Related]
15. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H
Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214
[TBL] [Abstract][Full Text] [Related]
17. Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping.
Pavlovich CP; Padilla-Nash H; Wangsa D; Nickerson ML; Matrosova V; Linehan WM; Ried T; Phillips JL
Genes Chromosomes Cancer; 2003 Jul; 37(3):252-60. PubMed ID: 12759923
[TBL] [Abstract][Full Text] [Related]
18. VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.
von Teichman A; Compérat E; Behnke S; Storz M; Moch H; Schraml P
Mod Pathol; 2011 Apr; 24(4):571-8. PubMed ID: 21151099
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient].
Liu N; Gong K; Zhang N; Guo HF; Na X; Wu G; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):115-7. PubMed ID: 15771820
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]